Introduction: The Microenvironmental Control of Cell Fate

Cell differentiation—the process by which unspecialized cells acquire specialized functions—is a cornerstone of developmental biology and regenerative medicine. For decades, researchers have cultured cells on flat plastic or glass surfaces, assuming that such two-dimensional (2D) environments adequately recapitulate the signals that guide differentiation in living tissues. However, mounting evidence demonstrates that the dimensionality of the culture environment profoundly influences how cells interpret biochemical and mechanical cues, ultimately steering differentiation pathways in ways that 2D systems cannot replicate.

This shift in understanding has propelled the development of three-dimensional (3D) culture platforms that more faithfully mimic the architecture, stiffness, and cell–cell interactions of native tissues. By examining the impact of culture dimensionality on differentiation, scientists are uncovering fundamental principles of morphogenesis and gaining practical tools for tissue engineering, drug screening, and disease modeling.

Understanding Culture Dimensionality

Culture dimensionality describes the spatial arrangement in which cells are grown in vitro. Historically, the vast majority of cell biology experiments have been performed in 2D monolayers, where cells adhere to a flat, rigid substrate (typically tissue culture polystyrene) and spread into unnatural geometries. In contrast, 3D cultures embed cells within an extracellular matrix (ECM)-like scaffold or allow them to self-assemble into spheroids, organoids, or hydrogel-based constructs.

The transition from 2D to 3D is not merely a matter of geometry. Three-dimensional systems recreate critical aspects of the in vivo niche: cell–matrix adhesion in three dimensions, gradients of oxygen and nutrients, physical confinement that alters cytoskeletal tension, and intercellular junctions that are polarised in a tissue-like manner. Common 3D platforms include natural hydrogels (e.g., collagen I, Matrigel), synthetic polymers (e.g., polyethylene glycol, alginate), porous scaffolds, and microfluidic devices.

Not all 3D systems are equivalent; the specific material properties—such as stiffness, porosity, degradation rate, and ligand density—each impinge on differentiation outcomes. Understanding these nuances is critical for designing experiments that accurately reflect in vivo biology.

How Culture Dimensionality Affects Cell Behavior

Cell Morphology and Adhesion

In 2D, cells attach to a single plane, forcing them to adopt a flattened, polarized morphology with distinct apical and basal surfaces. This artificial shape distorts the actin cytoskeleton, disrupts the normal distribution of integrin receptors, and alters the forces transmitted across the cell membrane. In 3D, cells are surrounded by ECM on all sides, allowing them to assume rounded, elongated, or branched morphologies that closely resemble their in vivo counterparts. For instance, mammary epithelial cells in 2D form flat sheets, whereas in 3D collagen gels they organize into hollow acini with correct apicobasal polarity—a prerequisite for differentiation into secretory or myoepithelial lineages.

The types of adhesions formed also differ: 2D cultures favor large, stable focal adhesions that generate high traction forces, while 3D environments promote smaller, more dynamic adhesions that are more sensitive to local ECM composition. This shift directly impacts downstream signaling pathways such as FAK–Src and RhoA–ROCK, which modulate differentiation.

Mechanotransduction Pathways

Cells sense and respond to mechanical cues from their surroundings through a process called mechanotransduction. Substrate stiffness, which is controlled by the dimensionality of the scaffold, is a dominant regulator of stem cell fate. In 2D, cells can only sense stiffness in the plane of adhesion, leading to a binary response: soft substrates (e.g., ~0.1–1 kPa) promote neurogenic differentiation, whereas stiffer substrates (e.g., ~10–40 kPa) bias toward osteogenic lineages. In 3D, the stiffness is experienced isotropically, and cells cannot flatten to maximize their contact with the substrate; thus, the same soluble factors and matrix ligands can produce different differentiation outcomes.

For example, human mesenchymal stem cells (MSCs) cultured in 3D hydrogels of intermediate stiffness (1–10 kPa) preferentially undergo chondrogenesis, even in medium that would normally drive osteogenesis on 2D plastic. The mechanism involves the Yes-associated protein (YAP) and transcriptional coactivator PDZ-binding motif (TAZ), which shuttle between the cytoplasm and nucleus in response to mechanical tension. In stiff 2D surroundings, YAP/TAZ remain nuclear, promoting proliferation and osteogenesis; in soft 3D environments, they are exported, allowing expression of chondrogenic and adipogenic genes.

Gene Expression Profiles

Gene expression in 3D cultures is consistently more similar to that of native tissues than to 2D monolayers. Transcriptomic analyses of hepatocytes, cardiomyocytes, and neural progenitors reveal that hundreds of differentiation-related genes are upregulated only when cells are allowed to organize in three dimensions. For instance, 3D-cultured embryonic stem cells (ESCs) show elevated expression of lineage-specific transcription factors (e.g., GATA4 for cardiac, FOXA2 for endoderm) compared to ESC aggregates in suspension or 2D colonies.

This improvement arises from the integration of multiple signals: paracrine factors are more concentrated in the confined 3D space, cell–cell junctions form properly, and the nuclear envelope experiences mechanical forces that regulate chromatin remodeling. Epigenetic modifications, including histone acetylation and DNA methylation patterns, are also altered in 3D cultures, making genes more accessible for activation.

Impact on Specific Differentiation Pathways

Stem Cell Differentiation

Both pluripotent stem cells (PSCs) and adult stem cells exhibit striking differences in their differentiation potential when cultured in 2D versus 3D. For example, directed differentiation of human induced pluripotent stem cells (iPSCs) into pancreatic β-cells requires a 3D suspension culture during the final maturation phase to achieve glucose-responsive insulin secretion. Similarly, the generation of functional retinal organoids from PSCs relies on 3D aggregates that self-pattern into laminated structures mimicking the retina.

For MSCs, 3D culture enhances the efficiency and homogeneity of differentiation into osteoblasts, chondrocytes, and adipocytes. MSC spheroids (pellet cultures) are the gold standard for chondrogenesis; cells in 2D micromass cultures, by contrast, form only a thin layer of cartilage-like matrix. The 3D geometry allows the accumulation of sulfated glycosaminoglycans and the establishment of a hypoxic core that upregulates hypoxia-inducible factor (HIF) signaling, a known enhancer of cartilage differentiation.

Osteogenesis

Osteogenic differentiation in 3D scaffolds is superior to 2D monolayers because 3D environments permit the formation of mineralized nodules and trabecular-like structures. Ceramic or polymer scaffolds with pore sizes of 100–300 μm enable cell penetration and vascularization in vivo, whereas 2D cultures only produce thin bone layers. The stiffness of the 3D matrix also accelerates the expression of alkaline phosphatase and osteocalcin. Recent studies using microporous annealed particle (MAP) hydrogels have demonstrated that MSCs seeded in 3D undergo more robust Runx2-driven osteogenesis than matched 2D controls.

Chondrogenesis

As noted, 3D culture is essential for chondrogenic differentiation. In addition to hydrogels, high-density pellet cultures are standard. The difference is so pronounced that 3D-cultured chondrocytes retain their phenotype for weeks, whereas 2D-expanded chondrocytes dedifferentiate into fibroblast-like cells within days. The 3D environment stabilizes the expression of SOX9, COL2A1, and aggrecan, while repressing COL1A1 and MMP13.

Neurogenesis

Neural stem cells differentiate into neurons, astrocytes, and oligodendrocytes. In 2D, they form a flat monolayer with limited neurite outgrowth. In 3D matrices such as Matrigel or alginate gels, cells extend long, complex neurites and form functional synapses. Three-dimensional brain organoids have become indispensable for studying neurodevelopmental disorders, as they recapitulate cortical layering and gyrification—a feat impossible in 2D. The dimensionality not only affects neuronal differentiation but also glial cell fate: oligodendrocyte precursor cells in 3D matrigel show enhanced differentiation into myelinating oligodendrocytes compared to 2D.

Comparison: 2D vs 3D in Regenerative Medicine

The choice between 2D and 3D culture depends on the experimental or therapeutic goal. For high-throughput drug screening and simple toxicity assays, 2D remains convenient and cost-effective. However, for applications requiring physiologically relevant differentiation—such as generating functional tissues for transplantation—3D systems are indispensable.

A major limitation of 2D is the lack of a native-like ECM environment and the absence of proper nutrient gradients. These shortfalls lead to altered metabolism and can mispredict drug responses. Conversely, 3D cultures introduce complexity: they are harder to image, more difficult to scale, and often require specialized materials. Newer platforms, such as 3D bioprinting and microfluidic organ-on-a-chip devices, can combine the benefits of both worlds by precisely controlling spatial cues while allowing high-resolution monitoring.

For regenerative medicine, 3D culture is the only way to engineer large tissue grafts that can integrate with host vasculature. Preclinical studies show that MSC-seeded 3D scaffolds accelerate bone and cartilage repair in animal models, whereas 2D-expanded cells injected as suspensions often die or fail to engraft. The better retention of committed differentiation in 3D also means that stem cells are less likely to form teratomas after transplantation.

Future Directions and Technologies

Advances in biomaterials and fabrication techniques are expanding the toolkit for studying culture dimensionality. 3D bioprinting can deposit cells and hydrogels layer-by-layer to create anatomically shaped constructs with controlled porosity and stiffness gradients. This approach allows researchers to recreate the zonal architecture of articular cartilage or the anisotropic structure of cardiac muscle, both of which are critical for proper differentiation.

Organoids derived from stem cells are already changing how we study development and disease. By fine-tuning matrix composition and topography, scientists can coax organoids to form miniature kidneys, livers, or stomachs with remarkable similarity to fetal tissue. Integrating microfluidic perfusion into organoid cultures further improves maturation and enables long-term maintenance.

Dynamic culture systems that apply cyclic stretch, compression, or fluid shear stress are being combined with 3D environments to mimic mechanical loading experienced in vivo. Bioreactors that control oxygen tension and pH gradients will be essential for scaling up differentiation protocols for clinical translation.

Another frontier is the development of smart biomaterials that present differentiation-inducing cues (such as growth factors or small molecules) in a spatiotemporally controlled manner. For example, hydrogels that release BMP-2 only in response to cell-secreted MMPs can guide osteogenesis at the surface while preserving the core of the construct for vascularization.

Finally, single-cell transcriptomics and spatial omics are revealing the heterogeneity of differentiation in 3D systems. These insights will allow us to design culture environments that drive uniform differentiation, reducing the risk of contamination by undifferentiated or off-target cells in therapeutic products.

Conclusion

The dimensionality of the culture environment is not a trivial variable—it fundamentally rewires how cells sense their world and decide their fate. From adhesion and cytoskeletal organization to gene expression and lineage commitment, every step of the differentiation pathway is shaped by the three-dimensional context. As we move toward clinical applications of stem cell therapies and engineered tissues, embracing realistic culture dimensionality is not optional but essential.

Continued innovation in 3D platforms—bioprinting, organoids, dynamic bioreactors—will provide the precision needed to control differentiation with surgical accuracy. By mimicking the native architecture and mechanics of the body, we can unlock the full potential of stem cells for regenerative medicine and deepen our understanding of development and disease.